Skip to main content
Premium Trial:

Request an Annual Quote

CollabRx, GeneInsight Collaborate on Sequencing Data

NEW YORK (GenomeWeb News) – CollabRx and GeneInsight today announced a joint initiative to make CollabRx's medical and scientific content accessible through GeneInsight's knowledge management platform.

The combined offering, the two companies said, will result in a medical informatics solution that supports genetic sequencing, interpretation, and reporting in the clinical laboratory. The offering will initially focus on cancer.

The analysis and interpretation of sequencing data is one of the greatest challenges facing clinicians, CollabRx and GeneInsight said. Their combined offering will allow clinical laboratories to catalog genetic variants from sequencing-based tests and link them with CollabRx's curated knowledge on available drugs and clinical trials.

The results will then be "streamlined through GeneInsight's networked infrastructure," so that clinical labs can update physicians on the most recent knowledge in order to better manage patient care.

"Our partnership with GeneInsight goes a long way toward enabling a truly integrated clinical laboratory workflow," Thomas Mika, chairman, president, and CEO of CollabRx, said in a statement.

The deal is the most recent in a string of transactions the San Francisco-based data analytics company has announced recently, following a partnership with Sengenics in cancer diagnostics; a deal with OncoDNA for the development of cancer mutation panels; and a distribution agreement with Projects In Knowledge.

Boston-based GeneInsight is a wholly owned bioinformatics subsidiary of integrated health system Partners Healthcare.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.